• Explore /
  • Poster
  • / A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer (KDOG 0501-P2).

A phase II trial of definitive chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil (DCF-R) in advanced esophageal cancer (KDOG 0501-P2).

Abstract Poster

Authors

null

Katsuhiko Higuchi

Department of Gastroenterology, Kitasato University East Hospital, Sagamihara, Japan

Katsuhiko Higuchi , Shouko Komori , Satoshi Tanabe , Chikatoshi Katada , Mizutomo Azuma , Hiromichi Ishiyama , Tohru Sasaki , Kenji Ishido , Natsuya Katada , Kazushige Hayakawa , Wasaburo Koizumi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2013 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Gastrointestinal (Noncolorectal) Cancer

Track

Gastrointestinal Cancer—Gastroesophageal, Pancreatic, and Hepatobiliary

Sub Track

Esophageal or Gastric Cancer

Clinical Trial Registration Number

000002029

Citation

J Clin Oncol 31, 2013 (suppl; abstr 4070)

DOI

10.1200/jco.2013.31.15_suppl.4070

Abstract #

4070

Poster Bd #

19H

Abstract Disclosures

Similar Posters

First Author: Tomoya Yokota

Poster

2018 Gastrointestinal Cancers Symposium

Results of neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fuluorouracil for advanced esophageal cancer.

Results of neoadjuvant chemoradiotherapy with docetaxel, cisplatin, and 5-fuluorouracil for advanced esophageal cancer.

First Author: Manabu Emi

First Author: Pol M. Specenier

First Author: Ricard Mesia Sr.